Top Markets
Coin of the day
OKYO Pharma Limited OKYO Pharma Limited

OKYO Pharma Limited

OKYO
Rangering i aksjer #39874
OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical... OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical stage, focuses on creating treatments for individuals experiencing inflammatory conditions of the eye and chronic ocular pain. Established in 2007 and headquartered in London, UK, the company's primary investigational drug is OK-101, aimed at addressing dry eye syndrome. Additionally, the firm is advancing OK-201, a preclinical analogue developed from bovine adrenal medulla, designed to alleviate neuropathic ocular pain.
Aksjekurs
$0.01904982
Sist synkronisert: 2023-05-19
Markedsverdi
$316.00K
Endring (1 dag)
-17.05%
Endring (1 år)
0.00%
Land
GB
Handel OKYO Pharma Limited (OKYO)

Kategori

Historikk for aksjesplitt for OKYO Pharma Limited (OKYO)
Aksjen OKYO Pharma Limited (symbol: OKYO) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 14, 2026.
Én OKYO-aksje kjøpt før Aug 14, 2026 tilsvarer i dag 0 OKYO-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE